Artificial heart maker Carmat announces progress on its Aeson product

Carmat SA

23/10/2023 06:07

PARIS, Oct 23 (Reuters) - Carmat  ALCAR.PA , the
artificial heart maker which this month got a 7 million euros
($7.40 million) lifeline to survive an imminent cash crunch, on
Monday announced solid progress for its Aeson artificial heart
product.
    Carmat said it had performed seven Aeson implants as part of
a clinical study in Paris and that it hoped to complete the
study in 2025, in line with the company's targets.
    ($1 = 0.9457 euros)

 (Reporting by Sudip Kar-Gupta; Editing by Jamie Freed)
 ((sudip.kargupta@thomsonreuters.com;))